Semaglutide 10MG

Description

Also known as: OGLE PLGLA1

CAS Number: 910463 68 2
Molecular Formula: C187H291N45O59
Molecular Weight: Approx. 4113.6 g/mol
Form: Lyophilized Powder
Quantity: 10 mg
Purity: 98 percent or higher (HPLC Verified)

Product Overview

This investigational GLP-1 pathway agonist is widely used in metabolic and endocrine research. Studies focus on its activity related to glucose balance, appetite models, and energy regulation. Its stabilized structure supports consistent performance and extended activity in controlled laboratory settings, making it a key compound in obesity and glycemic research. Research interest includes:

Type 2 diabetes and glycemic regulation models Appetite behavior and caloric intake studies Weight regulation and metabolic balance investigations GLP-1 receptor pathway and insulin related research

Storage and Handling

Store the lyophilized material at minus 20 degrees Celsius, protected from light and moisture. Reconstitute with sterile bacteriostatic water. After reconstitution, store at 2 to 8 degrees Celsius and use within standard research timelines. Limit freeze thaw cycles.

Research Use Only – Legal Disclaimer

All Eagle Peptides products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind. By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose. Use of these materials is entirely at your own risk. Eagle Peptides assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.